An inactivated cell culture japanese encephalitis vaccine (JEADVAX) formulated with delta inulin adjuvant provides robust heterologous protection against west nile encephalitis via cross-protective memory B cells and neutralizing antibody
West Nile virus (WNV), currently the cause of a serious U.S. epidemic, is a mosquito-borne flavivirus and member of the Japanese encephalitis (JE) serocomplex. There is currently no approved human WNV vaccine, and treatment options remain limited, resulti
|Collections||ANU Research Publications|
|Source:||Journal of Virology|
|01_Petrovsky_An_inactivated_cell_culture_2013.pdf||1.36 MB||Adobe PDF||Request a copy|
Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.